Read the latest from Baszucki Group and its partners.
March 4, 2024 — Ten emerging companies developing innovative mental health solutions will receive $1 million total in investment along with mentoring, coaching, and critical support to transform the lives of people facing mental illness.
February 21, 2024 — Three years after starting a keto diet with the help of Dr. Chris Palmer, Matt Baszucki no longer has symptoms of bipolar disorder.
February 15, 2024 — Baszucki Group announced the launch of a new partnership with McLean Hospital in Belmont, MA, on a clinical trial of a therapeutic ketogenic diet for bipolar disorder.
January 27, 2024 — Iain Campbell, Baszucki Brain Research Fund Fellow, has lived with bipolar disorder since he was young. After trying the ketogenic diet, he discovered profound improvements in his symptoms — and now wants to learn if it can do the same for others. He shared his recent findings at the Metabolic Health Summit in Clearwater, Florida, on Jan. 25, 2024.